How much cash does LeonaBio, Inc. Common Stock generate?

LeonaBio, Inc. Common Stock (LONA) generated -$52.0M in operating cash flow over the trailing twelve months.

What is LeonaBio, Inc. Common Stock's free cash flow?

After $63.0K of capital expenditures, LeonaBio, Inc. Common Stock's free cash flow was -$97.2M over the trailing twelve months, up 3.8% year over year.

Where does LeonaBio, Inc. Common Stock's cash flow data come from?

Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

LeonaBio, Inc. Common Stock LONA Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	-$105.61M-8.9%	-$96.94M+17.6%	-$117.67M-23.0%	-$95.64M-74.4%
Depreciation and amortization	$886K+0.1%	$885K-8.7%	$969K+14.7%	$845K+76.4%
Stock-based compensation	$6.1M-44.8%	$11.05M+4.0%	$10.62M+0.2%	$10.61M+129%
Change in accounts payable	-$21.34M—	——	$7.37M+251%	$2.1M-59.2%
Change in other assets	-$2.44M—	——	——	——
Change in other liabilities	-$59K—	——	——	——
Non-cash operating lease expense	$273K+13.3%	$241K+12.6%	$214K+5.4%	$203K+31.0%
Change in operating lease liabilities	-$414K-12.5%	-$368K-12.9%	-$326K—	——
Net cash from operating activities	-$45.73M+52.9%	-$97.17M+3.6%	-$100.75M-39.0%	-$72.47M-68.1%
Capital expenditures	——	——	$304K-73.4%	$1.14M-27.5%
Purchases of investments	$37.64M+166%	$14.13M-48.9%	$27.67M-71.0%	$95.29M-68.2%
Proceeds from maturities/sales of investments	$21.75M-68.5%	$69M-43.9%	$123.06M-20.1%	$154.09M—
Net cash from investing activities	——	$57.64M-39.4%	$95.09M+53.1%	$62.13M—
Net cash from financing activities	——	——	$493K-24.6%	$654K-99.3%
Net increase (decrease) in cash	$20.84M—	——	-$5.17M—	——
Accretion (Amortization) of Discounts and Premiums, Investments	$329K-36.1%	$515K-63.6%	$1.41M+235%	$422K+186%
Depreciation	$886K+0.1%	$885K-8.7%	$969K+14.7%	$845K+76.4%
Gain Loss From Milestone Liability Change In Fair Value	——	——	——	——
Increase Decrease In Accrued Legal Settlement	——	-$10M—	——	——
Increase (Decrease) in Insurance Settlements Receivable	——	-$1.63M-200%	$1.63M—	——
Operating lease liabilities	-$414K-12.5%	-$368K-12.9%	-$326K—	——
Other long-term liabilities	-$59K—	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	-$2.44M—	——	——	——
Operating lease right-of-use asset amortization	$273K+13.3%	$241K+12.6%	$214K+5.4%	$203K+31.0%
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale	$21.75M-68.5%	$69M-43.9%	$123.06M-20.1%	$154.09M-44.7%
Payments Of Stock Issuance Costs	$7.57M—	——	——	——
Proceeds From Exercise Of Common Stock Options And Issuance Of Common Stock Under Employee Stock Purchase Plan	$37K-80.9%	$194K—	——	——
Fair Value Adjustment Of Warrants	$4.58M—	——	——	——
Increase Decrease In Operating Lease Liability	-$414K-12.5%	-$368K-12.9%	-$326K—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does LeonaBio, Inc. Common Stock generate?: LeonaBio, Inc. Common Stock (LONA) generated -$52.0M in operating cash flow over the trailing twelve months.
What is LeonaBio, Inc. Common Stock's free cash flow?: After $63.0K of capital expenditures, LeonaBio, Inc. Common Stock's free cash flow was -$97.2M over the trailing twelve months, up 3.8% year over year.
Where does LeonaBio, Inc. Common Stock's cash flow data come from?: Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.